Testosterone replacement therapy for late-onset hypogonadism

Current trends in Korea

Young Hwii Ko, Je-Jong Kim

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Testosterone levels in men older than 40 years can decrease at a rate of 1%-2% per year, and reports show that more than 50% of 80-year-old men have testosterone levels consistent with hypogonadism. Late-onset hypogonadism (LOH) is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms of serum testosterone deficiency. In recent decades, the concept of LOH in ageing men has become familiar in European countries and the United States. It is also a topic of interest and debate throughout Korea. However, most of the data regarding advantages or disadvantages of testosterone replacement therapy (TRT) as treatment for LOH have been primarily obtained from studies on Western populations; therefore, studies of the effects of TRT in Asian men, who may have different serum testosterone compared to Western men, are needed. TRT is commonly prescribed in Korea, despite the paucity of studies on the effects of TRT in Asian populations. Data from various TRT studies based on Korean have shown its efficacy in increasing serum testosterone levels and improving subjective symptoms as assessed by questionnaires. Currently, patches and short-acting intramuscular injections are displaced by gels and long-acting formulations. However, to prevent overdiagnosis and overtreatment, indication for TRT should include both low testosterone levels and symptoms and signs of hypogonadism.

Original languageEnglish
Pages (from-to)563-568
Number of pages6
JournalAsian Journal of Andrology
Volume13
Issue number4
DOIs
Publication statusPublished - 2011 Jul 1

Fingerprint

Hypogonadism
Korea
Testosterone
Therapeutics
Serum
Intramuscular Injections
Population
Signs and Symptoms
Gels

Keywords

  • androgenic agents
  • androgens
  • late-onset hypogonadism
  • testosterone replacement therapy

ASJC Scopus subject areas

  • Urology

Cite this

Testosterone replacement therapy for late-onset hypogonadism : Current trends in Korea. / Ko, Young Hwii; Kim, Je-Jong.

In: Asian Journal of Andrology, Vol. 13, No. 4, 01.07.2011, p. 563-568.

Research output: Contribution to journalReview article

Ko, Young Hwii ; Kim, Je-Jong. / Testosterone replacement therapy for late-onset hypogonadism : Current trends in Korea. In: Asian Journal of Andrology. 2011 ; Vol. 13, No. 4. pp. 563-568.
@article{22e4945daa2343e983be6edf9164675a,
title = "Testosterone replacement therapy for late-onset hypogonadism: Current trends in Korea",
abstract = "Testosterone levels in men older than 40 years can decrease at a rate of 1{\%}-2{\%} per year, and reports show that more than 50{\%} of 80-year-old men have testosterone levels consistent with hypogonadism. Late-onset hypogonadism (LOH) is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms of serum testosterone deficiency. In recent decades, the concept of LOH in ageing men has become familiar in European countries and the United States. It is also a topic of interest and debate throughout Korea. However, most of the data regarding advantages or disadvantages of testosterone replacement therapy (TRT) as treatment for LOH have been primarily obtained from studies on Western populations; therefore, studies of the effects of TRT in Asian men, who may have different serum testosterone compared to Western men, are needed. TRT is commonly prescribed in Korea, despite the paucity of studies on the effects of TRT in Asian populations. Data from various TRT studies based on Korean have shown its efficacy in increasing serum testosterone levels and improving subjective symptoms as assessed by questionnaires. Currently, patches and short-acting intramuscular injections are displaced by gels and long-acting formulations. However, to prevent overdiagnosis and overtreatment, indication for TRT should include both low testosterone levels and symptoms and signs of hypogonadism.",
keywords = "androgenic agents, androgens, late-onset hypogonadism, testosterone replacement therapy",
author = "Ko, {Young Hwii} and Je-Jong Kim",
year = "2011",
month = "7",
day = "1",
doi = "10.1038/aja.2010.124",
language = "English",
volume = "13",
pages = "563--568",
journal = "Asian Journal of Andrology",
issn = "1008-682X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Testosterone replacement therapy for late-onset hypogonadism

T2 - Current trends in Korea

AU - Ko, Young Hwii

AU - Kim, Je-Jong

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Testosterone levels in men older than 40 years can decrease at a rate of 1%-2% per year, and reports show that more than 50% of 80-year-old men have testosterone levels consistent with hypogonadism. Late-onset hypogonadism (LOH) is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms of serum testosterone deficiency. In recent decades, the concept of LOH in ageing men has become familiar in European countries and the United States. It is also a topic of interest and debate throughout Korea. However, most of the data regarding advantages or disadvantages of testosterone replacement therapy (TRT) as treatment for LOH have been primarily obtained from studies on Western populations; therefore, studies of the effects of TRT in Asian men, who may have different serum testosterone compared to Western men, are needed. TRT is commonly prescribed in Korea, despite the paucity of studies on the effects of TRT in Asian populations. Data from various TRT studies based on Korean have shown its efficacy in increasing serum testosterone levels and improving subjective symptoms as assessed by questionnaires. Currently, patches and short-acting intramuscular injections are displaced by gels and long-acting formulations. However, to prevent overdiagnosis and overtreatment, indication for TRT should include both low testosterone levels and symptoms and signs of hypogonadism.

AB - Testosterone levels in men older than 40 years can decrease at a rate of 1%-2% per year, and reports show that more than 50% of 80-year-old men have testosterone levels consistent with hypogonadism. Late-onset hypogonadism (LOH) is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms of serum testosterone deficiency. In recent decades, the concept of LOH in ageing men has become familiar in European countries and the United States. It is also a topic of interest and debate throughout Korea. However, most of the data regarding advantages or disadvantages of testosterone replacement therapy (TRT) as treatment for LOH have been primarily obtained from studies on Western populations; therefore, studies of the effects of TRT in Asian men, who may have different serum testosterone compared to Western men, are needed. TRT is commonly prescribed in Korea, despite the paucity of studies on the effects of TRT in Asian populations. Data from various TRT studies based on Korean have shown its efficacy in increasing serum testosterone levels and improving subjective symptoms as assessed by questionnaires. Currently, patches and short-acting intramuscular injections are displaced by gels and long-acting formulations. However, to prevent overdiagnosis and overtreatment, indication for TRT should include both low testosterone levels and symptoms and signs of hypogonadism.

KW - androgenic agents

KW - androgens

KW - late-onset hypogonadism

KW - testosterone replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=79960048496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960048496&partnerID=8YFLogxK

U2 - 10.1038/aja.2010.124

DO - 10.1038/aja.2010.124

M3 - Review article

VL - 13

SP - 563

EP - 568

JO - Asian Journal of Andrology

JF - Asian Journal of Andrology

SN - 1008-682X

IS - 4

ER -